Frank de Vries

Professor

Prof. Frank de Vries started a PhD in pharmaco-epidemiology at Utrecht University in 2002 on side effects of use of inhaled corticosteroids. Since then, he has worked for the Medicine and Healthcare products Regulatory Agency. He has obtained several research grants and prizes, including the Swierenga award for respiratory disease, an NWO Veni grant and the Kohn prize from the UK National Osteoporosis Foundation. His work has been published in various journals including JAMA, the NEJM and BMJ. He is on secondment at the Utrecht Institute for Pharmaceutical Sciences, the Netherlands. He is a visiting scientist at the MRC Lifecourse Epidemiology Unit in Southampton, UK. Frank works as a hospital pharmacist in the Maastricht UMC+, apotheek.mumc.nl/en.

Frank’s current research activities mainly focus on effects of drugs in patients with diabetes mellitus and movement disorders. As the department’s head of research, he oversees other research lines on personalised medicine in the areas of lung oncology and psychiatric disorders.

Department of Clinical Pharmacy & Toxicology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
T: +31(0)43 387 18 81

  • 2013
    • Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E. J., Neef, C. K., Cooper, C. S., & de Vries, F. (2013). Risk of fracture in patients with Parkinson's disease. Osteoporosis International, 24(8), 2283-2290. https://doi.org/10.1007/s00198-013-2300-2
    • Knapen, L. M., Dittrich, S. T., de Vries, F., Starup-Linde, J., Vestergaard, P., Henry, R. M. A., Stolk, L. M., Neef, C. K., & Bazelier, M. T. (2013). Use of biguanides and the risk of colorectal cancer: a register-based cohort study. Current Drug Safety, 8(5), 349-356. https://doi.org/10.2174/15680266113136660068
  • 2012
    • Klop, C., de Vries, F., Lalmohamed, A., Mastbergen, S. C., Leufkens, H. G. M., Noort-van der Laan, W. H., Bijlsma, J. W. J., & Welsing, P. M. J. (2012). COX-2-Selective NSAIDs and Risk of Hip or Knee Replacements: A Population-Based Case-Control Study. Calcified Tissue International, 91(6), 387-394. https://doi.org/10.1007/s00223-012-9646-x
    • Lalmohamed, A., Vestergaard, P., Cooper, C., de Boer, A., Leufkens, H. G. M., van Staa, T. P., & de Vries, F. (2012). Timing of Stroke in Patients Undergoing Total Hip Replacement and Matched Controls A Nationwide Cohort Study. Stroke, 43(12), 3225-3229. https://doi.org/10.1161/STROKEAHA.112.668509
    • Bazelier, M. T., Bentzen, J., Vestergaard, P., Stenager, E., Leufkens, H. G. M., van Staa, T-P., & de Vries, F. (2012). The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers. Multiple Sclerosis Journal, 18(11), 1609-1616. https://doi.org/10.1177/1352458512442755
    • Lalmohamed, A., Vestergaard, P., Klop, C., Grove, E. L., de Boer, A., Leufkens, H. G. M., van Staa, T. P., & de Vries, F. (2012). Timing of Acute Myocardial Infarction in Patients Undergoing Total Hip or Knee Replacement A Nationwide Cohort Study. Archives of Internal Medicine, 172(16), 1229-1235. https://doi.org/10.1001/archinternmed.2012.2713
    • Lalmohamed, A., de Vries, F., Bazelier, M. T., Cooper, A., van Staa, T-P., Cooper, C., & Harvey, N. C. (2012). Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ (e), 345, [e5085]. https://doi.org/10.1136/bmj.e5085
    • van Leeuwen, R. W., & de, V. F. (2012). Use of hormonal contraceptives and risk of HIV-1 transmission.Lancet Infectious Diseases, 12(7), 508-509. https://doi.org/10.1016/S1473-3099(12)70113-5
    • Khong, T. P., de Vries, F., Goldenberg, J. S. B., Klungel, O. H., Robinson, J. N., Ibanez, L., & Petri, H. (2012). Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States. Calcified Tissue International, 91(1), 24-31. https://doi.org/10.1007/s00223-012-9603-8
    • Bazelier, M. T., van Staa, T. P., Uitdehaag, B. M. J., Cooper, C., Leufkens, H. G. M., Vestergaard, P., Herings, R. M. C., & de Vries, F. (2012). Risk of fractures in patients with multiple sclerosis A population-based cohort study. Neurology, 78(24), 1967-1973. https://doi.org/10.1212/WNL.0b013e318259e0ff
    • Bazelier, M. T., Vestergaard, P., Gallagher, A. M., van Staa, T-P., Cooper, C., Leufkens, H. G. M., & de Vries, F. (2012). Risk of Fracture with Thiazolidinediones: Disease or Drugs?Calcified Tissue International, 90(6), 450-457. https://doi.org/10.1007/s00223-012-9591-8
    • Lalmohamed, A., Welsing, P. M. J., Lems, W. F., Jacobs, J. W. G., Kanis, J. A., Johansson, H., De Boer, A., & De Vries, F. (2012). Calibration of FRAX (R) 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporosis International, 23(3), 861-869. https://doi.org/10.1007/s00198-011-1852-2
  • 2011
    • de Vries, F. (2011). Inverse association between duration of use of Acid-suppressive medications and fracture risk...Arch Intern Med. 2011 Jun 13;171(11): 998-1004. Archives of Internal Medicine, 171(11), 1044. https://doi.org/10.1001/archinternmed.2011.226
  • 2007
    • de, V. F., Pouwels, S., Lammers, JWJ., Leufkens, HGM., Bracke, M., Cooper, C., van, S. TP., de Vries, F., Lammers, J. W. J., Leufkens, H. G. M., & van Staa, T. P. (2007). Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.Journal of Internal Medicine, 261(2), 170-177.